Skip to content

Effect of different milk fractions on the metabolic response in healthy and prediabetic volunteers

Effect of different milk fractions on the metabolic response in healthy and prediabetic volunteers - MIPROMET

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00005682
Enrollment
45
Registered
2014-02-25
Start date
2009-10-05
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glucose homeostasis

Interventions

Group 1: Healthy volunteer 50g whey protein 50g maltodextrin19 10g lactulose 2g Hydroxyproline vanilla- or lemonflavour solved in 300ml water Group 2: Healthy volunteer 50g casein 50g maltodextrin19 1

Sponsors

Kraft Foods R&D Inc.Zweigniederlassung München
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 74 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for healthy volunteers: -age between 20 and 50 years -BMI 20 up to 28 kg/m2 -written consent Inclusion criteria for prediabetic volunteers: -age between 20 and 50 years -confirmation of the prediabetic state corresponding to the definition of the WHO. ( Glucose tolerance test: baseline/fasting state = 6,1 mmol/l (= 110 mg/dl) and < 7,0 mmol/l (< 126 mg/dl) in venous plasma or = 5,6 mmol/l (= 100 mg/dl) and < 6,0 mmol/l (< 109 mg/dl) in capillary whole blood and/or 2 hour sample = 7,8 mmol/l (= 140 mg/dl) and <11,1 mmol/l (< 200 mg/dl) in venous plasma or capillary whole blood -written consent Inclusion criteria for diabetic patients: -age up to 74 years -single Metformin therapy -written consent

Exclusion criteria

Exclusion criteria: Exclusion criteriy for healthy volunteers: -chronic diseases e.g. diabetes mellitus, inflammatory diseases, cardiovaskular diseases, infectious diseases -severe depression -known drug- and alcoholabuse -medication -smoker Exclusion criteria for prediabetic volunteers: -chronic diseases e.g.iinflammatory diseases, cardiovaskular diseases, infectious diseases -severe depression -known drug- and alcoholabuse -medication -smoker Exclusion criteria for diabetic patients: -severe depression -known drug- and alcoholabuse -smoker

Design outcomes

Primary

MeasureTime frame
Hemocue: glucose Multiplex: insulin,GIP, C-peptides, glucagon Elisa: GLP-1 time span: up to 240 min after intake in the fasting state reading points: 0, 15, 30, 45, 60, 90, 120, 180, and 240 min

Secondary

MeasureTime frame
LC-MS/MS: acetaminophen, amino acids, acylcarnitine Multiplex: ghrelin Spectrometer: superoxiddismutase, catalase, glutathionreductase, dipeptidylpeptidase IV, ß-hydroxybutyrate, non esterified free fatty acids visual analogue scale feeling of hunger time span: up to 240 min after intake in the fasting state reading points: 0, 15, 30, 45, 60, 90, 120, 180, and 240 min reading points for visual analogue scale: every 30 min reading points forSOD, catalase, glutathione reductase: 0, 30, 240 min

Countries

Germany

Contacts

Public ContactAnja Höfle

Wissenschaftszentrum WeihenstephanLehrstuhl für ErnährungsphysiologieTechnische Universität München

anja.hoefle@tum.de08161-71 3997

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 18, 2026